|
1
|
Enewold L, Zhu K, Ron E, Marrogi AJ,
Stojadinovic A, Peoples GE and Devesa SS: Rising thyroid cancer
incidence in the United States by demographic and tumor
characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev.
18:784–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fofi C, Festuccia F, Barberi S, Apponi F,
Chiacchiararelli L, Scopinaro F, Punzo G and Menè P: Hemodialysis
in patients requiring 131I treatment for thyroid carcinoma. Int J
Artif Organs. 36:439–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu XH, Chen GG, Vlantis AC and van
Hasselt CA: Iodine mediated mechanisms and thyroid carcinoma. Crit
Rev Clin Lab Sci. 46:302–318. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Renehan AG, Soerjomataram I, Tyson M,
Egger M, Zwahlen M, Coebergh JW and Buchan I: Incident cancer
burden attributable to excess body mass index in 30 European
countries. Int J Cancer. 126:692–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikiforov YE: Is ionizing radiation
responsible for the increasing incidence of thyroid cancer? Cancer.
116:1626–1628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ushenkova LN, Koterov AN and Biryukov AP:
RET/PTC Gene rearrangements in the sporadic and radiogenic thyroid
tumors: Molecular genetics, radiobiology and molecular
epidemiology. Radiats Biol Radioecol. 55:229–249. 2015.(In
Russian). PubMed/NCBI
|
|
8
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J
and Liu M: Long intergenic noncoding RNA HOTAIR is overexpressed
and regulates PTEN methylation in laryngeal squamous cell
carcinoma. Am J Pathol. 182:64–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nie Y, Liu X, Qu S, Song E, Zou H and Gong
C: Long non-coding RNA HOTAIR is an independent prognostic marker
for nasopharyngeal carcinoma progression and survival. Cancer Sci.
104:458–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu H, Lv Z, An C, Shi M, Pan W, Zhou L,
Yang W and Yang M: Onco-lncRNA HOTAIR and its functional genetic
variants in papillary thyroid carcinoma. Sci Rep. 6:319692016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li HM, Yang H, Wen DY, Luo YH, Liang CY,
Pan DH, Ma W, Chen G, He Y and Chen JQ: Overexpression of lncRNA
HOTAIR is associated with poor prognosis in thyroid carcinoma: A
study based on TCGA and GEO data. Horm Metab Res. 49:388–399. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Zeng W, Liu C, Wang S, Xiong Y, Guo
Y, Li X, Sun S, Chen T, Maimaiti Y, et al: Diagnostic accuracy of
ultrasonographic features for lymph node metastasis in papillary
thyroid microcarcinoma: A single-center retrospective study. World
J Surg Oncol. 15:322017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ
and Lee JH: Diagnostic performance of CT in detection of metastatic
cervical lymph nodes in patients with thyroid cancer: A systematic
review and meta-analysis. Eur Radiol. 29:4635–4647. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhan J, Diao X, Chen Y, Wang W and Ding H:
Predicting cervical lymph node metastasis in patients with
papillary thyroid cancer (PTC)-Why contrast-enhanced ultrasound
(CEUS) was performed before thyroidectomy. Clin Hemorheol
Microcirc. 72:61–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di W, Li Q, Shen W, Guo H and Zhao S: The
long non-coding RNA HOTAIR promotes thyroid cancer cell growth,
invasion and migration through the miR-1-CCND2 axis. Am J Cancer
Res. 7:1298–1309. 2017.PubMed/NCBI
|
|
21
|
Zhang Y, Yu S, Jiang L, Wang X and Song X:
HOTAIR is a promising novel biomarker in patients with thyroid
cancer. Exp Ther Med. 13:2274–2278. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nasser MW, Datta J, Nuovo G, Kutay H,
Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reid JF, Sokolova V, Zoni E, Lampis A,
Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino
G, et al: miRNA profiling in colorectal cancer highlights miR-1
involvement in MET-dependent proliferation. Mol Cancer Res.
10:504–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo Y, Cui X, Zhao J, Han Y, Li M, Lin Y,
Jiang Y and Lan L: Cells susceptible to epithelial-mesenchymal
transition are enriched in stem-like side population cells from
prostate cancer. Oncol Rep. 31:874–884. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu YW, Sun M, Xia R, Zhang EB, Liu XH,
Zhang ZH, Xu TP, De W, Liu BR and Wang ZX: LincHOTAIR
epigenetically silences miR34a by binding to PRC2 to promote the
epithelial-to-mesenchymal transition in human gastric cancer. Cell
Death Dis. 6:e18022015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu Y, Lv F, Liang D, Yang Q, Zhang B, Lin
H, Wang X, Qian G, Xu J and You W: HOTAIR may regulate
proliferation, apoptosis, migration and invasion of MCF-7 cells
through regulating the P53/Akt/JNK signaling pathway. Biomed
Pharmacother. 90:555–561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao Z, Xu X, Liu Y, Chao H, Lin C, Li Z,
You Y, Liu N and Ji J: CBX7 negatively regulates migration and
invasion in glioma via Wnt/β-catenin pathway inactivation.
Oncotarget. 8:39048–39063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Zhang N, Zhu J, Hong XT, Liu H, Ou
YR, Su F, Wang R, Li YM and Wu Q: Downregulated connexin32 promotes
EMT through the Wnt/β-catenin pathway by targeting Snail expression
in hepatocellular carcinoma. Int J Oncol. 50:1977–1988. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sawa M, Masuda M and Yamada T: Targeting
the Wnt signaling pathway in colorectal cancer. Expert Opin Ther
Targets. 20:419–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sánchez-Hernández D, Sierra J,
Ortigão-Farias J and Guerrero I: The WIF domain of the human and
Drosophila Wif-1 secreted factors confers specificity for Wnt or
Hedgehog. Development. 140:3849–3858. 2013. View Article : Google Scholar
|
|
31
|
Zhou Z, Liu Y, Ma M and Chang L: Knockdown
of TRIM44 inhibits the proliferation and invasion in papillary
thyroid cancer cells through suppressing the Wnt/β-catenin
signaling pathway. Biomed Pharmacother. 96:98–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
